West Pharmaceutical Services, Inc.

WSTNYSEUSD
340.96 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
341.51
0.55 (0.16%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
341.51
0.55 (0.16%)
🔴Market: CLOSED

West Pharmaceutical Services, Inc. (WST) is currently trading at $340.96. Technicals currently rate "Neutral" while our fundamental analysis reads "Strong Buy". Key drivers include a robust Altman Z-Score, a strong Piotroski F-Score of 7/9 and a bullish Golden Cross on the moving averages. Furthermore, WST is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Jul 31, 2026.

Open?$339.49
High?$342.75
Low?$334.38
Prev. Close?$340.96
Volume?1.0M
Avg. Volume?898.2K
VWAP?$339.00
Rel. Volume?1.17x
Bid / Ask
Bid?$272.06 × 100
Ask?$388.00 × 100
Spread?$115.94
Midpoint?$330.03
Valuation & Ratios
Market Cap?24.0B
Shares Out?70.4M
Float?70.2M
Float %?99.4%
P/E Ratio?42.48
P/B Ratio?8.02
EPS?$8.03
Dividend?0.24%
Ex-Dividend?N/A
RelatedEHCCHE
News
Profile
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Employees
10.8K
Market Cap
24.0B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
1973-01-02
Address
530 HERMAN O. WEST DRIVE
EXTON, PA 19341
Phone: (610) 594-2900
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookStrong Buy
Strong SellNeutralStrong Buy
F-Score?
88
Z-Score?
100
Momentum?
92
Short Sent.?
69
Piotroski F-Score?7/9Strong
Altman Z-Score?16.59Safe
Confidence?77%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?3.36%Low
Short Interest?2.4M
Days to Cover?3.6
Free Float70.2M
Avg Daily Volume659.7K
Settlement Date2026-07-15
Financial Health
Current Ratio?2.82Strong
Quick Ratio?2.12Strong
Cash Ratio?0.68Adequate
Debt/Equity?0.07Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score
33/100
P/E?
Peers
33
S&P
17
42.5PRICEY
P/B?
Peers
67
S&P
23
8.02HIGH
P/S?
Peers
33
S&P
16
7.21HIGH
P/FCF?
Peers
33
S&P
9
54.9PRICEY
EV/EBITDA?
Peers
33
S&P
14
26.3HIGH
EV/Sales?
Peers
33
S&P
19
7.14HIGH
Returns & Efficiency
ROE?
Peers
33
S&P
64
18.9%STRONG
ROA?
Peers
67
S&P
84
13.9%STRONG
Cash Flow & Enterprise
FCF?$436.9M
Enterprise Value?$23.8B
Fundamentals ratios updated end of day